Amneris Luque
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
HIV Infections | 11 | 1999 | 136 |
Why?
|
Papillomaviridae | 3 | 1999 | 37 |
Why?
|
Pasteurella Infections | 2 | 2006 | 2 |
Why?
|
Aztreonam | 2 | 2006 | 2 |
Why?
|
Meningitis, Bacterial | 2 | 2006 | 9 |
Why?
|
Papillomavirus Infections | 2 | 1999 | 39 |
Why?
|
HIV-1 | 6 | 1999 | 93 |
Why?
|
Anti-Bacterial Agents | 2 | 2006 | 195 |
Why?
|
Cervical Intraepithelial Neoplasia | 2 | 2006 | 16 |
Why?
|
Bites and Stings | 2 | 2006 | 6 |
Why?
|
Pasteurella multocida | 2 | 2006 | 1 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2006 | 55 |
Why?
|
Anti-HIV Agents | 3 | 2005 | 44 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 1996 | 41 |
Why?
|
Tumor Virus Infections | 2 | 1996 | 31 |
Why?
|
Phosphonic Acids | 1 | 2007 | 9 |
Why?
|
Occupational Health Services | 1 | 2007 | 11 |
Why?
|
Student Health Services | 1 | 2007 | 5 |
Why?
|
Chemoprevention | 1 | 2007 | 12 |
Why?
|
Lamivudine | 1 | 2007 | 18 |
Why?
|
Universities | 1 | 2007 | 28 |
Why?
|
Adenine | 1 | 2007 | 26 |
Why?
|
Zidovudine | 1 | 2007 | 23 |
Why?
|
Occupational Exposure | 1 | 2007 | 53 |
Why?
|
Vaginal Smears | 3 | 1999 | 31 |
Why?
|
RNA, Viral | 3 | 1999 | 91 |
Why?
|
Nontuberculous Mycobacteria | 1 | 1998 | 6 |
Why?
|
Middle Aged | 10 | 1999 | 1161 |
Why?
|
Mycobacterium Infections, Nontuberculous | 1 | 1998 | 14 |
Why?
|
Osteomyelitis | 1 | 1998 | 39 |
Why?
|
Genotype | 2 | 2006 | 175 |
Why?
|
Trifluridine | 1 | 1996 | 3 |
Why?
|
DNA, Viral | 2 | 2006 | 98 |
Why?
|
Adult | 10 | 1998 | 1317 |
Why?
|
Simplexvirus | 1 | 1996 | 33 |
Why?
|
Female | 11 | 1999 | 1643 |
Why?
|
Prevalence | 2 | 2006 | 281 |
Why?
|
Cats | 2 | 2006 | 71 |
Why?
|
New York | 3 | 1999 | 422 |
Why?
|
Herpesviridae Infections | 1 | 1996 | 25 |
Why?
|
Cervix Uteri | 2 | 1999 | 38 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 85 |
Why?
|
Humans | 17 | 1996 | 1856 |
Why?
|
Antiviral Agents | 1 | 1996 | 91 |
Why?
|
Vagina | 2 | 2008 | 30 |
Why?
|
Benzoxazines | 1 | 2011 | 14 |
Why?
|
Virus Shedding | 1 | 2010 | 8 |
Why?
|
Kenya | 1 | 2010 | 4 |
Why?
|
Washington | 1 | 2010 | 12 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2010 | 8 |
Why?
|
HIV Protease Inhibitors | 1 | 2011 | 25 |
Why?
|
HIV Seronegativity | 2 | 1999 | 13 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 96 |
Why?
|
Vaginosis, Bacterial | 1 | 2008 | 5 |
Why?
|
Interleukin-1beta | 1 | 2008 | 36 |
Why?
|
Interleukin-8 | 1 | 2008 | 54 |
Why?
|
Public Health Administration | 1 | 2007 | 14 |
Why?
|
Drug Combinations | 1 | 2007 | 95 |
Why?
|
Indinavir | 1 | 2006 | 6 |
Why?
|
Microbial Sensitivity Tests | 1 | 2007 | 71 |
Why?
|
Pyrimidinones | 1 | 2006 | 14 |
Why?
|
Bilirubin | 1 | 2006 | 29 |
Why?
|
Patient Compliance | 1 | 2007 | 113 |
Why?
|
Interleukin-6 | 1 | 2008 | 145 |
Why?
|
Sex Factors | 1 | 2007 | 284 |
Why?
|
Logistic Models | 1 | 2007 | 251 |
Why?
|
Male | 8 | 1996 | 1553 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 279 |
Why?
|
Cross-Sectional Studies | 2 | 1999 | 253 |
Why?
|
Hemolysis | 1 | 2003 | 31 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 174 |
Why?
|
Erythrocytes | 1 | 2003 | 109 |
Why?
|
Rhabdomyolysis | 1 | 2001 | 9 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2001 | 10 |
Why?
|
Aged | 2 | 1999 | 988 |
Why?
|
Retrospective Studies | 1 | 2007 | 653 |
Why?
|
Ultrasonography | 1 | 2003 | 89 |
Why?
|
Streptococcus | 1 | 2001 | 34 |
Why?
|
Vaginal Douching | 2 | 2008 | 2 |
Why?
|
Risk Factors | 1 | 2007 | 555 |
Why?
|
Antigens, CD57 | 1 | 1999 | 3 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1999 | 37 |
Why?
|
Leukoplakia, Hairy | 1 | 1999 | 3 |
Why?
|
Animals | 2 | 2006 | 1031 |
Why?
|
Cytomegalovirus Infections | 1 | 1999 | 39 |
Why?
|
Herpesvirus 4, Human | 1 | 1999 | 34 |
Why?
|
Streptococcal Infections | 1 | 2001 | 54 |
Why?
|
Fingers | 1 | 1998 | 37 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1999 | 91 |
Why?
|
Acyclovir | 1 | 1996 | 28 |
Why?
|
Drug Resistance | 1 | 1996 | 83 |
Why?
|
Skin | 1 | 1996 | 177 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1999 | 224 |
Why?
|
Drug Monitoring | 1 | 2011 | 33 |
Why?
|
Adolescent | 3 | 1999 | 891 |
Why?
|
Fungi | 1 | 2010 | 15 |
Why?
|
HIV | 1 | 2011 | 32 |
Why?
|
Bacteria | 1 | 2010 | 42 |
Why?
|
Vaginal Discharge | 1 | 2008 | 2 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2008 | 2 |
Why?
|
Lopinavir | 1 | 2006 | 11 |
Why?
|
Inflammation | 1 | 2010 | 208 |
Why?
|
Cytokines | 1 | 2010 | 207 |
Why?
|
Regression Analysis | 1 | 2008 | 256 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 121 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 27 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 191 |
Why?
|
Cohort Studies | 1 | 2008 | 332 |
Why?
|
Multivariate Analysis | 1 | 2006 | 225 |
Why?
|
Erythrocyte Indices | 1 | 2003 | 5 |
Why?
|
Blood Viscosity | 1 | 2003 | 9 |
Why?
|
Hematocrit | 1 | 2003 | 60 |
Why?
|
United States | 1 | 2010 | 604 |
Why?
|
Exotoxins | 1 | 2001 | 9 |
Why?
|
Bacteremia | 1 | 2001 | 25 |
Why?
|
Shock, Septic | 1 | 2001 | 40 |
Why?
|
Cytomegalovirus | 1 | 1999 | 42 |
Why?
|
Antibodies, Viral | 1 | 1999 | 104 |
Why?
|
